Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neogenomics Inc 9490 NEOGENOMICS WAY FORT MYERS FL 33912 USA

www.neogenomics.com Employees: 2,500 P: 239-768-0600 F: 239-690-4237

Sector:

Medical

Description:

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.

Key Statistics

Overview:

Market Capitalization, $K 1,276,052
Enterprise Value, $K 1,116,432
Shares Outstanding, K 129,812
Float, K 126,697
% Float 97.60%
Short Interest, K 8,890
Short Float 6.85%
Days to Cover 5.52
Short Volume Ratio 0.73
% of Insider Shareholders 2.40%
% of Institutional Shareholders 98.50%

Financials:

Annual Sales, $ 727,330 K
Annual Net Income, $ -108,030 K
Last Quarter Sales, $ 190,170 K
Last Quarter Net Income, $ -9,880 K
EBIT, $ -115,880 K
EBITDA, $ -46,060 K

Growth:

1-Year Return -3.50%
3-Year Return -45.36%
5-Year Return -77.27%
5-Year Revenue Growth 63.65%
5-Year Earnings Growth -371.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.06 on 02/17/26
Next Earnings Date 05/05/26
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NEO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -3.10%
Return-on-Assets % -1.85%
Profit Margin % -14.85%
Debt/Equity 0.00
Price/Sales 1.75
Price/Cash Flow 29.34
Price/Book 1.53
Book Value/Share 6.47
Interest Coverage -28.41
60-Month Beta 1.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar